Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Francois, S.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(2)
+
-
Availability
Open access
(1)
+
-
Metadata Only
(1)
+
-
Faculty
Leiden University Medical Center (LUMC)
(2)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(2)
+
-
Author
Beguin, Y.
(2)
+
-
Biezen, A. van
(2)
+
-
Chevalier, P.
(2)
+
-
Dubois, V.
(2)
+
-
El-Cheikh, J.
(2)
+
-
Finke, J.
(2)
+
-
Francois, S.
(2)
+
-
Garban, F.
(2)
+
-
Garderet, L.
(2)
+
-
Gluckman, E.
(2)
+
-
Iacobelli, S.
(2)
+
-
Koster, L.
(2)
+
-
Kroger, N.
(2)
+
-
Lioure, B.
(2)
+
-
Maillard, N.
(2)
+
-
Meijer, E.
(2)
+
-
Michallet, M.
(2)
+
-
Passweg, J.
(2)
+
-
Petersen, E.
(2)
+
-
Ruggeri, A.
(2)
+
-
Russell, N.
(2)
+
-
Schipperus, M.
(2)
+
-
Sobh, M.
(2)
+
-
Tabrizi, R.
(2)
+
-
Tholouli, E.
(2)
+
-
Volin, L.
(2)
+
-
Show more
Language
en
(2)
+
-
Search results
(1 - 2 of 2)
show grid
show list
save search
Sobh, M.; Michallet, M.; Dubois, V.; Iacobelli, S.; Koster, L.; Biezen, A. van; ... ; Kroger, N.
2017
Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party
Article / Letter to editor
open access
Michallet, M.; Sobh, M.; Dubois, V.; Iacobelli, S.; Koster, L.; Biezen, A. van; ... ; EBMT Chronic Malignancies Working
2016
Salvage use of allogeneic HSCT after reduced intensity conditioning from unrelated donors in multiple myeloma: outcomes from 10/10 HLA-matched unrelated donors, 9/10 HLA-mismatched unrelated donors and cord blood. A study by the EBMT and Eurocord
Article / Letter to editor
metadata only